Bit of Background These new classes of antiobesity medications (ie, the GLP-1 agonists and dual agonists), referred to in this article as weight management medications, arent really new.1-4 The basic science and pharmaceutical research and development to bring these to market began more than two decades ago when two scientists, Matthias Tschop, MD, and Richard DiMarchi, PhD, hypothesized that the actions of various gut hormones may offer safe and unprecedented weight loss
Hospitals, primary care clinics, and community health centers are increasingly incorporating obesity treatment into their chronic disease management plans
International Agency for Research on Cancer Handbook Working Group
Distribution matters: Aim for 25-40g protein per meal across 3-4 meals
Their main mechanism is to delay gastric emptying (taking longer for food to pass from the stomach to the small intestine), lowering blood sugar, and regulating insulin
References Kannan, N